What is carcinoid syndrome?

Carcinoid syndrome can affect your quality of life and occasionally put you in danger. Our experienced specialists can offer relief, including effective carcinoid tumor treatment and safeguards for your health.

Carcinoid syndrome refers to a set of symptoms tied to tumors called carcinoids and the release of the hormone serotonin.

Carcinoids are a type of neuroendocrine tumor (NET), found in cells that resemble nerves but which can also release hormones. Many carcinoids are benign (noncancerous), but they can also turn malignant (cancerous). They develop most often in the gastrointestinal (GI) tract but can also form in the lungs and airways. Occasionally, they develop in other areas of the body.

Up to 40 percent of GI carcinoids result in carcinoid syndrome. A much smaller percentage of lung carcinoids cause this complication.

Carcinoid syndrome symptoms

Carcinoid syndrome can cause a handful of symptoms. Some people develop a single symptom, while others get a mix.

Symptoms include:

  • Flushing: Roughly four in five people with carcinoid syndrome experience flushing. It causes the face and neck to turn red and feel warm. It can also cause hypotension (drop in blood pressure) and tachycardia (fast heart rate).
  • Diarrhea: Up to half of people with carcinoid syndrome develop diarrhea, typically watery and persistent. You may also get belly cramps and not feel like eating.
  • Wheezing: Some people experience trouble breathing, with their lungs making a whistling sound.
  • Spider veins: Thin veins can appear on the lips and nose and turn purple.

Symptoms can get worse when you feel stressed, exercise intensely, drink alcohol or eat a large meal. You may also experience additional symptoms directly from the tumor if it presses on other tissue or blocks the GI tract.

What triggers carcinoid syndrome?

Some carcinoids — most commonly from tumors in the small intestine, appendix and start of the colon — make and release serotonin. Occasionally, carcinoids in the lungs and ovaries do, too.

Serotonin from carcinoids in the lungs or ovaries goes straight to the bloodstream, where it can trigger symptoms.

For GI tumors, the extra serotonin typically gets processed by the liver, with no effect on the body. Eventually, though, tumors can metastasize (spread) to the liver and interfere with its function, allowing serotonin into the blood. Liver metastases may also release additional serotonin.

National Cancer Institute "Designated Comprehensive Cancer Center" badge on top of exterior shot of the Perelman Center for Advanced Medicine

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Patient stories

Tool measures tumor growth for less uncertainty between scans

Neuroradiologists have developed the first-ever tool that gives a real-time assessment of an individual’s tumor, and relieves anxiety between scans.

CNN anchor Kasie Hunt had brain surgery at Penn

Before starting her own daily news show, journalist Kasie Hunt came to Penn Medicine for a growing brain tumor that was causing painful headaches.

Epilepsy surgery gives patient a new lease on life

Minimally invasive laser interstitial thermal therapy (LITT) surgery reduced the epilepsy symptoms a patient had experienced for more than 30 years.

A hole in the heart repaired

After a heart attack, Vilma Patel's family brought her from India to Lancaster for lifesaving VSD repair.

Faith, fate, and families

At the Basser Center for BRCA at Penn, a unique philanthropic investment is making rapid progress toward preventing and treating heritable cancer.

Patient puts national spotlight on cancer clinical trials

As Kate Korson recently shared on Good Morning America, both she and her mother participated in clinical trials at Abramson Cancer Center.

From a bone-on-bone jaw to living the life she planned

Penn Medicine’s expert team helped Kristina navigate a complex diagnosis and nickel allergy to alleviate her jaw pain and improve her bite.

A grateful patient pays it forward to treat uterine cancers

Dalia Jakas credits her doctor with curing her uterine cancer without harming her quality of life. Now, she’s paying it forward for future patients.

A personal perspective on gender-affirming care

A lifelong performer shares how she began enjoying life even more after facial feminization surgery, as part of her gender-affirming care.

Finding triple-negative breast cancer at 33, she chose ‘Team Penn’

Shocked to learn she had stage III breast cancer, Kate Korson knew just where to go. She flew home to Penn Medicine, where a clinical trial saved her life.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.